Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04755348 · ClinicalTrials.gov registry record · NA

A Study to Assess the Pharmacokinetics of Oral Nicotine Pouches and Lozenges in Healthy Adults

A NA study of Tobacco Use and Cigarette Smoking, sponsored by British American Tobacco (Investments) Limited.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT04755348 is a NA study of Tobacco Use and Cigarette Smoking that has completed, run by British American Tobacco (Investments) Limited. The registered enrollment target is 36 participants, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04755348, a NA study of Tobacco Use and Cigarette Smoking, has completed, sponsored by British American Tobacco (Investments) Limited.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

This is a randomised, open-label, confined, cross-over study to evaluate the nicotine pharmacokinetics (PK) of modern oral nicotine pouches and nicotine lozenges carried out in 36 healthy adult subjects who smoke cigarettes and who may have experience using smokeless tobacco (loose or pouches).

Interventions

  • OTHER Product A
  • OTHER Product B
  • OTHER Product C
  • OTHER Product D
  • OTHER Product E

Study Locations (1)

Kansas

  • Altasciences Clinical Kansas, Inc. - Overland Park

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2021-02-18
Est. Completion 2021-03-25
Phase NA

What the Registry Record Tells You About NCT04755348

The ClinicalTrials.gov registry entry for NCT04755348 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (91% lower). The listed sponsor is British American Tobacco (Investments) Limited, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Tobacco Use appearing as the primary indexed condition, and to 5 interventions - of which Product A is the first listed.

NCT04755348 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT04755348 about?

NCT04755348 is a clinical study titled "A Study to Assess the Pharmacokinetics of Oral Nicotine Pouches and Lozenges in Healthy Adults". This is a randomised, open-label, confined, cross-over study to evaluate the nicotine pharmacokinetics (PK) of modern oral nicotine pouches and nicotine lozenges carried out in 36 healthy adult subjects who smoke cigarettes and who may have experience using smokeless tobacco (loose or pouches).

What is the current status of trial NCT04755348?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2021-02-18. Estimated completion is 2021-03-25.

What conditions does trial NCT04755348 study?

This clinical trial studies the following conditions: Tobacco Use, Cigarette Smoking, Tobacco Smoking.

What interventions are being tested in trial NCT04755348?

The interventions under investigation include: Product A (OTHER), Product B (OTHER), Product C (OTHER), Product D (OTHER), Product E (OTHER).

Who is sponsoring clinical trial NCT04755348?

This trial is sponsored by British American Tobacco (Investments) Limited, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04755348 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.